patent cliff
Point at which a product's patent expires and competitors can copy it, eroding premium pricing.
As defined in DuPont: Two Centuries of Chemistry
Where it comes up · 6
- Dolby: The Sound Standard2 claims
- Investing in Healthcare2 claims
- DuPont: Two Centuries of Chemistry1 claim
- InterDigital: Setting Wireless Standards1 claim
- Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]1 claim
- Anne-Marie Peterson - The Capital System - [Invest Like the Best, EP.364]1 claim
Most important claims · 8 of 8Search all claims for “patent cliff” →
- Over the past 20 years big pharma divested most internal early-stage R&D and pivoted to buying startups from private markets or public biotechs, creating a forced buyer spending $20 to $30 billion a year and a structural opportunity for venture capital because patent cliffs require replacing expiring products.Investing in Healthcare
- Today's specialty chemical becomes tomorrow's commodity: once patents expire or competitors copy a product well enough that customers don't care, prices fall and premium pricing disappears.DuPont: Two Centuries of Chemistry
- Pharma is only about 10 percent of health care spending yet spends roughly 20 percent of sales on R&D, and its manufacturing complexity creates a moat that blocks generics even after patents expire, as with Vertex in cystic fibrosis.Anne-Marie Peterson - The Capital System - [Invest Like the Best, EP.364]
- Unlike a pharmaceutical company facing a patent cliff on a single drug, InterDigital has no patent cliff because patents expire after 20 years, technology from older generations is largely obsolete, and the company keeps obtaining new patents, including for 6G.InterDigital: Setting Wireless Standards
- Dolby's patent cliff is well contained because it repeatedly extends protection windows and migrates customers from older formats such as Dolby Digital, which is mostly off-patent in most markets, to newer formats such as Dolby Digital Plus, AC-4, and Atmos that carry fresh protection.Dolby: The Sound Standard
- Big device makers such as Apple, Amazon, or Google are restrained from building in-house alternatives by Dolby's patent portfolio, its habit of migrating customers to newer codecs that extend protection windows, and the brand transference that rivals cannot easily copy.Dolby: The Sound Standard
- Pharma companies know the expiration dates of their drug patents in advance and can estimate the revenue they will lose at each patent cliff, creating an inescapable need to replace expiring products with new ones.Investing in Healthcare
- Alex worries that if innovation incentives weaken, companies will stop investing in fundamental, decade-long research, instead marketing old drugs, extending patents, and investing in hard-to-copy products like radiotherapeutics and CAR Ts.Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]